Micron Products, Inc. Products Announces ISO 13485:2003 Certification
FITCHBURG, MA--(Marketwire - January 20, 2010) - Micron Products, Inc. ("Micron"), a wholly owned subsidiary of Arrhythmia Research Technology, Inc. (the "Company") (NYSE Amex: HRT), is proud to announce its attainment of International Organization for Standardization (ISO) 13485:2003 certification of its quality management system.
ISO 13485:2003 is the internationally recognized standard for the development, production, and servicing of medical products. In order to obtain ISO 13485 certification, a company must demonstrate the ability to provide medical devices and related services that consistently meet customer and regulatory requirements applicable to medical devices and related services. During the certification process, Micron partnered with TUV Rheinland, a world renowned international service group that serves as an ISO registrar, auditing the safety and quality of new and existing products, systems, and services.
"The accomplishment of ISO 13485 certification further demonstrates our commitment to the highest standards in the medical device industry," said James E. Rouse, President and Chief Executive Officer of the Company. "This certification from the leader in ISO registration validates all of the hard work the Company has put into both product quality and compliance."
Link to the ISO Certification: http://www.micronproducts.com/isocertificate.pdf
The Company through its wholly owned subsidiary Micron Products, Inc. manufactures silver plated and non-silver plated conductive resin sensors and distributes metal snaps used in the manufacture of disposable ECG, EEG, EMS and TENS electrodes. Micron's MIT division provides end-to-end product life cycle management through a comprehensive portfolio of value-added services such as design, engineering, prototyping, manufacturing, machining, assembly and packaging. MIT manufactures custom injection molded products for medical, electronic, industrial and consumer applications, and provides high end mold design, manufacturing and precision machining for various industries. The Company's products also include proprietary signal-averaging electrocardiography (SAECG) software used in the detection of potentially lethal heart arrhythmias.
For more information please check our websites:
http://www.micronintegrated.com
Forward-looking statements made herein are based on current expectations of
the Company that involve a number of risks and uncertainties and should not
be considered as guarantees of future performance. The factors that could
cause actual results to differ materially include: our ability to maintain
our current pricing model and/or decrease our cost of sales; continued
availability of supplies or materials used in manufacturing at competitive
prices; volatility in commodity and energy prices and our ability to offset
higher costs with price increases; the costs inherent with complying with
new statutes and regulations; variability of customer delivery
requirements; our ability to efficiently integrate future acquisitions and
other new lines of business that the Company may enter in the future. More
information about factors that potentially could affect the Company's
financial results is included in the Company's filings with the Securities
and Exchange Commission, including its Annual Report on Form 10-K for the
year ended December 31, 2008.